PU-H71-d7 Hydrate
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
PU-H71-d7 Hydrate Product Information
PU-H71-d7 Hydrate is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-99119.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
PU-H71-d7 Hydrate
CAT No.
CS-T-99119
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C18H14D7IN6O3S
Molecular Weight
535.41
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
PU-H71-d7 Hydrate is supplied with detailed characterization data compliant with regulatory guideline. PU-H71-d7 Hydrate can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
Labelled PU-H71 (P840122). It is a potent Hsp90 inhibitor (IC50 = 50 nM). Hsp90 plays a critical role in modulating the activity of many cell signaling proteins and are an attractive target for anti-cancer therapeutics. Studies indicate that Hsp90 inhibitors may serve as potential anti-Parkinson's disease.
Synonyms
PU-H71-d7 Hydrate
Application Notes
Labelled PU-H71 (P840122). It is a potent Hsp90 inhibitor (IC50 = 50 nM). Hsp90 plays a critical role in modulating the activity of many cell signaling proteins and are an attractive target for anti-cancer therapeutics. Studies indicate that Hsp90 inhibitors may serve as potential anti-Parkinson's disease.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.